Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × nilotinib × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Leukemia, Myeloid, Chronic-Phase 6 Neoplasm Metastasis 4 Philadelphia Chromosome 2 Neoplasms 2 Neoplasm, Residual 2 Myeloproliferative Disorders 2 Leukemia 2 Synovitis, Pigmented Villonodular 1 Sarcoma 1 Ovarian Neoplasms 1 Leukemia, Myeloid 1 Hematologic Diseases 1 Giant Cell Tumor of Tendon Sheath 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Blast Crisis 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡